TIMER partners
Ten beneficiaries across five countries
Italy, Brazil, Switzerland, the United Kingdom and Ireland
The consortium combines academic groups in inflammation biology with companies working on therapeutic compounds and research services.
The beneficiary list, countries and scientific contacts below are reproduced from the portal record. Institutional websites are given where they are known; contact by email was not published in the record.
TIMER beneficiaries
Telormedix SA
Switzerland · contact Alcide Barberis
company partnerALTA Ricerca e Sviluppo in Biotecnologie S.r.l.u.
Italy · contact Paola Cesaroni
company partnerBrazilian participation
Three of the ten beneficiaries are Brazilian institutions, in Belo Horizonte, São Paulo and Rio de Janeiro. Their preclinical models of immunopathology cover joint, skin, lung and colon tissue. Read how the work is organised.